Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder : Core Common Protocol

17/11/2016
02/07/2024
EU PAS number:
EUPAS16088
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

178-CL-113_Protocol Version 7.0_For ENCePP Reg

English (625.71 KB - PDF) View document
Updated protocol

178-cl-113-clp-07-reissue-v8dot1-en-final-02

First published: 22/02/2024
English (1.33 MB - PDF) View document
Study results
Study results

178-cl-113-clrr-04-disc01-en-final-02

English (904.23 KB - PDF) View document
Study report
Other information